膵外分泌機能不全(Exocrine Pancreatic Insufficiency):治療薬開発パイプライン動向2018

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIPR2016218)
◆英語タイトル:Exocrine Pancreatic Insufficiency-Pipeline Insights, 2018
◆発行会社/調査会社:DelveInsight
◆商品コード:DIPR2016218
◆発行日:2019年05月
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:約60
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後3営業日)
◆販売価格オプション(消費税別)
Single User(1名使用)USD1,250 ⇒換算¥137,500見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[膵外分泌機能不全(Exocrine Pancreatic Insufficiency):治療薬開発パイプライン動向2018]についてメールでお問い合わせはこちら
※本調査レポートでは、世界における膵外分泌機能不全(Exocrine Pancreatic Insufficiency)の治療薬開発パイプライン動向について調査・分析し、企業別開発中の治療薬、各臨床試験段階における製品リスト及び比較分析、薬剤候補のプロファイル、治療薬の評価、開発中止又は開発休止中の薬剤リスト等をお届けしています。また、膵外分泌機能不全(Exocrine Pancreatic Insufficiency)治療薬開発に取り組んでいる企業情報も提供しています。

・膵外分泌機能不全(Exocrine Pancreatic Insufficiency)の概要

・膵外分泌機能不全(Exocrine Pancreatic Insufficiency)の治療薬パイプライン概要

・企業別開発中の膵外分泌機能不全(Exocrine Pancreatic Insufficiency)治療薬

・後期治験段階の薬剤(Filed & Phase III):比較分析

・中期治験段階の薬剤(Phase II):比較分析

・初期治験段階の薬剤(Phase I & IND Filed):比較分析

・前臨床段階の薬剤:比較分析

・薬剤候補のプロファイル

・膵外分泌機能不全(Exocrine Pancreatic Insufficiency)治療薬の評価
  - 単剤治療薬別評価
  - 併用治療薬別評価
  - 投与経路別評価
  - 分子種類別評価

・開発が中止された薬剤リスト

・開発休止中の薬剤リスト

・膵外分泌機能不全(Exocrine Pancreatic Insufficiency)治療薬開発に取り組んでいる企業リスト

・図表一覧
*** レポート概要(サマリー)***

SUMMARY
DelveInsight’s, “ Exocrine Pancreatic Insufficiency-Pipeline Insights, 2018”, report provides in depth insights on the pipeline drugs and their development activities around the Exocrine Pancreatic Insufficiency. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Exocrine Pancreatic Insufficiency. DelveInsight’s Report also assesses the Exocrine Pancreatic Insufficiency therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.


Scope
• The report provides competitivepipeline landscape of Exocrine Pancreatic Insufficiency
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Exocrine Pancreatic Insufficiency pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Exocrine Pancreatic Insufficiency and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


*** レポート目次(コンテンツ)***

Table of Contents
• Exocrine Pancreatic Insufficiency Overview
• Exocrine Pancreatic Insufficiency Pipeline Therapeutics
• Exocrine Pancreatic Insufficiency Therapeutics under Development by Companies
• Exocrine Pancreatic Insufficiency Filed and Phase III Products
• Comparative Analysis
• Exocrine Pancreatic Insufficiency Phase II Products
• Comparative Analysis
• Exocrine Pancreatic Insufficiency Phase I and IND Filed Products
• Comparative Analysis
• Exocrine Pancreatic Insufficiency Discovery and Pre-Clinical Stage Products
• Comparative Analysis
• Drug Candidate Profiles
• Exocrine Pancreatic Insufficiency – Therapeutics Assessment
• Assessment by Monotherapy Products
• Assessment by Combination Products
• Assessment by Route of Administration
• Assessment by Molecule Type
• Exocrine Pancreatic Insufficiency – Discontinued Products
• Exocrine Pancreatic Insufficiency – Dormant Products
• Companies Involved in Therapeutics Development for Exocrine Pancreatic Insufficiency
• Appendix
• Methodology
• Contact Us
• Disclaimer

List of Tables
• Number of Products under Development for Exocrine Pancreatic Insufficiency, 2018
• Number of Products under Development by Companies
• Comparative Analysis by Filed and Phase III Products, 2018
• Comparative Analysis Phase II Products, 2018
• Comparative Analysis Phase I and IND Filed Products, 2018
• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2018
• Drug Candidates Profiles
• Exocrine Pancreatic Insufficiency Assessment by Monotherapy Products
• Exocrine Pancreatic Insufficiency Assessment by Combination Products
• Exocrine Pancreatic Insufficiency Assessment by Route of Administration
• Exocrine Pancreatic Insufficiency Assessment by Stage and Route of Administration
• Exocrine Pancreatic Insufficiency Assessment by Molecule Type
• Exocrine Pancreatic Insufficiency Assessment by Stage and Molecule Type
• Exocrine Pancreatic Insufficiency Therapeutics – Discontinued Products
• Exocrine Pancreatic Insufficiency Therapeutics – Dormant Products
• Products under Development by Companies, 2018


List of Figures
• Number of Products under Development for Exocrine Pancreatic Insufficiency, 2018
• Filed and Phase III Products, 2018
• Phase II Products, 2018
• Phase I and IND Filed Products, 2018
• Discovery and Pre-Clinical Stage Products, 2018
• Exocrine Pancreatic Insufficiency Assessment by Monotherapy Products
• Exocrine Pancreatic Insufficiency Assessment by Combination Products
• Exocrine Pancreatic Insufficiency Assessment by Route of Administration
• Exocrine Pancreatic Insufficiency Assessment by Stage and Route of Administration
• Exocrine Pancreatic Insufficiency Assessment by Molecule Type
• Exocrine Pancreatic Insufficiency Assessment by Stage and Molecule Type


*** レポートのキーワード ***

膵外分泌機能不全(Exocrine Pancreatic Insufficiency)、治療薬、医薬品、薬剤、製薬企業、研究開発、治験、パイプライン

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 半導体堆積の世界市場
    This report studies Semiconductor Deposition in Global market, especially in North America, Europe, China, Japan, Korea and Taiwan, focuses on top manufacturers in global market, with sales, price, revenue and market share for each manufacturer, covering Applied Materials ASM International Hitachi K …
  • ケーブル導管システムの世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2022)
    Cable Conduit Systems refer to a subset of cable management systems used for protection and routing of electrical wires/cables. These are tubular structures designed to carry wires and cables and are available in rigid as well as flexible forms. Electrical conduit systems are available in both metal …
  • ICカードインテリジェントロックの世界市場2016
    The Global IC Card Intelligent Lock Industry 2016 Market Research Report is a professional and in-depth study on the current state of the IC Card Intelligent Lock industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry …
  • グローバル製薬業界における事業提携、ライセンシング、投資及びM&A動向:Q4 2013
    Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2013 Summary GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2013” report is an essential source of data and trend analysis on partnerships, licensing, mergers an …
  • 世界のティンパノメーター市場2016
    Notes:Production, means the output of Tympanometers Revenue, means the sales value of Tympanometers This report studies Tympanometers in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, …
  • ECG装置の北米市場
    KEY FINDINGSNorth America ECG Equipment market is anticipated to grow at $1869 million in 2016 and is projected to reach $2977 million by 2024, growing at a CAGR of 6.08%, during the forecast period 2016-2024.The forecast period for the market is from 2016 to 2025 and the base year deliberated for t …
  • エンドウ豆タンパクの世界市場2016-2020
    About the Pea Protein Market Pea protein is extracted from yellow peas, known as Pisum sativum, and has a typical legume amino acid profile. Being highly nutritive and functional, pea protein has gained a strong foothold in the plant-based protein market. It is also a clean-label product with non-al …
  • アプリケーションプロセッサの世界市場2015-2019
    About application processor An application processor is a SoC, designed to support applications running in an operating system environment such as Android, Apple iOS, Windows CE, or Symbian. As a battery occupies the maximum space in a mobile device, central processor unit, graphics processing unit, …
  • シクロヘキサンの世界市場動向・予測
    The present report is an essential resource for a one looking for detailed information on the world cyclohexane market. The report covers data on global, regional and national markets including present and future trends for supply and demand, prices, and downstream industries. In addition to the ana …
  • 世界及び中国の自動販売機(VEM)市場2015
    The Global and Chinese Vending Machine (VEM) Industry, 2010-2020 Market Research Report is a professional and in-depth study on the current state of the global Vending Machine (VEM) industry with a focus on the Chinese market. The report provides key statistics on the market status of the Vending Ma …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIPR2016218 )"膵外分泌機能不全(Exocrine Pancreatic Insufficiency):治療薬開発パイプライン動向2018" (英文:Exocrine Pancreatic Insufficiency-Pipeline Insights, 2018)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。